Belgorod State University, Belgorod, Russia.
Arch Razi Inst. 2022 Feb 28;77(1):315-321. doi: 10.22092/ARI.2021.356614.1883. eCollection 2022 Feb.
Chronic kidney disease (CKD) is an established independent risk factor for cardiovascular disease (CVD) and is caused by chronic pyelonephritis (CP). This study aimed to investigate the effect of the association of cardiovascular markers with the course of CP on the comorbidity of CP with ischemic heart disease. The study participants included 125 patients with CP without symptoms of urinary tract obstruction who were divided into three groups. The first group (n=45) consisted of patients with recurrent CP (CPr) three or more times per year. The second group (n=42) included patients with active phase pyelonephritis (CPa), with a frequency of two times or less per year, with concomitant pathology (stable coronary artery disease, functional class I - II), and the third group (n=38) included patients with an inactive phase of the disease (CPi), with a history of pyelonephritis of at least five years. The patients' carotid artery augmentation index (AI %) and the change in the diameter of the brachial artery (D %) in CPi, CPa, and CPr groups were 8.44±1.76, 15.47±4.00, 11.71±1.70, 13.81±3.06, 12.75±2.55 and 6.54±3.27, respectively. The left ventricular ejection fraction (EF) index in the three study groups was estimated to be 68.92±3.76, 64.76±2.75, and 66.28±3.45%, respectively. An analysis of the results showed the most significant changes in the parameters of the cardiovascular system in patients with a comorbid and relapsing course of CP. The results showed a significant increase in pulmonary artery diameter, EF, left ventricular pressure and volume, pulse wave velocity in the aorta, and vascular resistance index.
慢性肾脏病(CKD)是心血管疾病(CVD)的既定独立危险因素,由慢性肾盂肾炎(CP)引起。本研究旨在探讨心血管标志物与 CP 病程的相关性对 CP 合并缺血性心脏病的影响。研究对象包括 125 名无尿路梗阻症状的 CP 患者,他们分为三组。第一组(n=45)由每年复发 CP(CPr)三次或以上的患者组成。第二组(n=42)包括每年复发两次或以下、伴有并存病理(稳定型冠状动脉疾病、功能 I-II 级)的活动期肾盂肾炎(CPa)患者,第三组(n=38)包括疾病的非活动期(CPi)患者,有肾盂肾炎病史至少五年。CPi、CPa 和 CPr 组患者的颈动脉增强指数(AI%)和肱动脉直径变化(D%)分别为 8.44±1.76、15.47±4.00、11.71±1.70、13.81±3.06、12.75±2.55 和 6.54±3.27。三组患者的左心室射血分数(EF)指数分别估计为 68.92±3.76、64.76±2.75 和 66.28±3.45%。结果分析显示,合并和复发性 CP 患者的心血管系统参数变化最显著。结果显示肺动脉直径、EF、左心室压力和容量、主动脉脉搏波速度和血管阻力指数显著增加。